Find Tenders in Tower Hamlets

Single-molecule counting and digital quantification of RNA molecules instrument

Description: The Contracting Authority requires a multiplexed molecular analysis system capable of performing direct, amplification-free, digital quantification of gene expression (mRNA and miRNA) and protein targets from limited and potentially degraded clinical samples. The system will be used primarily for patient-derived specimens, including FFPE and other clinically archived materials, where RNA quantity and integrity may be limited. The solution must therefore demonstrate high sensitivity, reproducibility, and robustness to sample degradation. The required system must provide a complete sample-to-data workflow, enabling end-to-end processing, automated or semi-automated operation, and integrated data analysis suitable for use by scientific staff without advanced bioinformatics expertise. To access this opportunity, you must first register as a "Supplier" on the Authority's e-tendering portal here: https://atamis-1928.my.site.com/s/Welcome

Summary: The current procurement process is initiated by the Secretary of State for Health and Social Care, acting as part of the Crown through the UK Health Security Agency, located in London, United Kingdom. The active tender is for a "Single-molecule counting and digital quantification of RNA molecules instrument" intended for medical equipment use. The procurement is in the tender stage and operates under an open procedure, inviting submissions via a specified e-tendering portal. The tender period concludes on 28th May 2026, and the award is expected by 10th June 2026. This procurement is of particular interest to businesses specializing in high-sensitivity molecular analysis systems, given the instrument's stringent requirements for sensitivity, reproducibility, and robustness.

NEL GP Healthcare Services - Tranche 3

Description: NHS North East London Integrated Care Board (the Authority) invites Healthcare providers to submit Expressions of Interest (EOI) and completed Invitation to Tender (ITT) submissions from all suitable providers for the delivery of Healthcare services for the following five sites: 1. Barking Havering 2. Victoria & Five Elms 3. Loxford 4. Lucas Avenue 5. Rainham A key emphasis is placed on Neighbourhood Integration, working collaboratively within the wider Primary Care Network, alongside community and acute care services, third sector organisations, and other professional groups, to improve health outcomes for the registered patient population. Providers will be expected to deliver accessible, patient-centred primary care whilst actively engaging with integrated care initiatives and local health improvement priorities. This notice is published in accordance with the Health Care Services (Provider Selection (read more...)

Summary: The procurement process initiated by the NHS North East London Integrated Care Board focuses on the provision of GP healthcare services across five sites, specifically Barking Riverside, Victoria & Five Elms, Loxford, Lucas Avenue, and Rainham. This tender, titled "NEL GP Healthcare Services - Tranche 3", falls under the services category and is classified under general-practitioner services. The procurement process is currently in the tender phase, with a final submission deadline extended to 8th May 2026. The contracts are set in the United Kingdom, particularly the London areas of Barking & Dagenham, Redbridge, and Havering, and managed by the NHS London Commercial Hub as part of a competitive process under the Health Care Services (Provider Selection Regime) Regulations 2023.

BCG Vaccine & TB Skin Test (2027)

Description: The UK Health Security Agency (UKHSA) wishes to establish contracts for the provision of i) Bacillus Calmette-Guerin (BCG) vaccine and ii) intradermal diagnostic skin test for the detection of Mycobacterium tuberculosis infection

Summary: The UK Health Security Agency, acting through the Secretary of State for Health and Social Care, is in the planning phase of a procurement process titled "BCG Vaccine & TB Skin Test (2027)." This initiative aims to establish contracts for Bacillus Calmette-Guérin vaccines and intradermal diagnostic skin tests for detecting Mycobacterium tuberculosis infections. It falls under the goods category and targets suppliers of vaccines and diagnostic agents. The procurement process is scheduled to commence on 1st April 2027, with the contract potentially extending until 31st March 2031. The process is currently engaged in preliminary market engagement activities, having issued a questionnaire to UK suppliers in March 2026 to gather insights into product specifications and supply chain capabilities.

Request for Information - Medical Device Quality Control (QC) Testing Capacity

Description: 1. The purpose of this document is to enhance the Authority's understanding of the marketplace and its options for sourcing for a potential future requirement. 2. The issuance of this request for information (RFI) does not constitute a sourcing exercise nor will the Authority pay any costs incurred in the preparation of a response to this RFI. 3. The UK Health Security Agency's (UKHSA) key objectives for this RFI are: a. understand the ability of the marketplace to fulfil its requirements. b. refine the scope of the requirements to best align to the marketplace; and c. inform the Authority's chosen route to market to best enable competition 4. The key dates for this RFI are as follows: 1. RFI Published: 27th April 2026 2. RFI Response: 17:00 - (read more...)

Summary: The Secretary of State for Health and Social Care, acting through the UK Health Security Agency (UKHSA), has initiated a procurement process with a Request for Information (RFI) concerning the enhancement of medical device Quality Control (QC) testing capacity. This tender falls within the services category, specifically focusing on technical inspection and testing services, laboratory services, auditing, and industrial quality control. It is currently in the planning stage, with a market engagement notice published on 27th April 2026. Interested parties have the opportunity to submit their responses by 12th May 2026. The procurement is located in London, UK, and aims to explore opportunities for collaboration with UK-based organisations in quality control testing for medical devices as part of the UKHSA’s mission to safeguard public health.

TEN-2627-003 (PA2023) - Board Effectiveness Review

Description: The Supplier will objectively review the effectiveness of the Nest Corporation Board and the overall governance framework (comprising Committees, Panels, the Nest Invest Board and individual Board Members). The objective of this external effectiveness review will be to evaluate whether Nest's governance framework- particularly the role, composition, and operation of the Nest Corporation Board-is adequately positioned to deliver effective strategic leadership, oversight and accountability in the context of Nest's evolving scale and complexity; and to identify any changes required to ensure the Board remains fit for purpose in the medium to long term as Nest pursues its 2030 strategy, responds to regulatory and political developments, and strengthens its focus on investment, customer outcomes, and organisational resilience. As an additional part of this review, the Supplier should also consider (read more...)

Summary: The National Employment Savings Trust (NEST) Corporation, based in London, is actively seeking a supplier for the Board Effectiveness Review as part of their 2030 strategy. With an open competition procurement method, the tender invites suppliers within the services category, particularly focusing on performance review services in governance. The tender process is at the stage of submission, with key deadlines including the end of the enquiry period on 8th May 2026 and the tender submission deadline on 27th May 2026. Interested parties are encouraged to submit bids electronically, with the contract set to commence on 1st July 2026 and conclude by 29th January 2027, with a potential extension if required.

EME - RFI - Electric Vehicle Scheme - Employee Benefits

Description: The Financial Ombudsman Service (FOS) is undertaking pre-market engagement to inform the development of a potential future procurement for an Electric Vehicle (EV) benefit scheme for employees. This notice invites suppliers with experience in the provision and operation of EV benefit schemes, including associated digital platforms, administration services, and any value-added offerings, to participate in a Request for Information (RFI). Due to this early engagement, FOS are unable to estimte the value of the future contract. The engagement is intended to gather insight on market capability, delivery models, and commercial approaches to support consideration of a future requirement. It does not constitute a procurement or invitation to tender, does not involve supplier selection or assessment, and does not create any obligation on FOS to commence a procurement or (read more...)

Summary: The Financial Ombudsman Service Limited, a public authority within sub-central government in the United Kingdom, is at the planning stage of a procurement process titled "EME - RFI - Electric Vehicle Scheme - Employee Benefits". This procurement process is aimed at developing an employee benefits scheme centred around electric vehicles, with potential delivery across the UK. Suppliers interested in the planning phase are encouraged to respond to a Market Engagement Questionnaire by 15 May 2026, with possible clarification discussions scheduled for the week commencing 25 May 2026 via Microsoft Teams. The questionnaire is accessible through their eSourcing tool, with final submissions due by 1 June 2026. This process is aligned with the category of goods procurement and involves careful pre-market engagement to gather insights and inform future requirements.

Income Protection Research

Description: Fair4All Finance's mission is to reduce financial exclusion by ensuring that everyone has access to a suite of fair and affordable financial products and services that meet their immediate needs and help build their long term financial resilience. We believe that having the right levels of insurance and protection are a key enabler to achieving financial wellbeing and giving people peace of mind and greater financial certainty when faced with unexpected circumstances and life events. We want this research to identify both the issues facing different groups of consumers on precarious incomes in accessing a range of protection products that meet their needs, and the barriers faced by insurers in providing appropriate and affordable options.

Summary: FAIR4ALL FINANCE LIMITED, a public undertaking based in London, is inviting tenders for a project titled "Income Protection Research." The procurement process is in the tender stage and focuses on research services within the financial inclusion industry, specifically addressing income protection. The contract value is set at £125,000 GBP, and the procurement method is an open competition, below threshold. Interested parties should submit their proposals via the Fair4all Finance Electronic Tendering Site on In-Tend. The tender period ends on 22 May 2026, with enquiries closing on 15 May 2026. The project delivery location is specified as UKI31, United Kingdom, with the contract expected to run from 16 June 2026 to 31 December 2026.

Centralised Adult Flu Procurement

Description: Central Adult Flu Vaccine Procurement and Distribution Project Update To Industry.

Summary: The ongoing procurement process, initiated by the Secretary of State for Health and Social Care, through the UK Health Security Agency (UKHSA), aims to centralise the procurement and distribution of adult flu vaccines. This initiative falls under the goods category within the healthcare industry, specifically focusing on vaccines as per the CPV classification 33651600. The project is currently at the tender update stage, with a major amendment in April 2026 indicating the commencement of centralised procurement and distribution would potentially begin in the winter of 2029/2030, ensuring ample preparation time. The procurement involves consultations with primary care representatives to stabilise market impacts, and efforts are aligned with the NHS Vaccination Strategy (2023). The UKHSA, located at 10 South Colonnade, London, serves as the buyer overseeing this project.

HAR6171 Smithy Street - Infill Development Scheme

Description: London Borough of Tower Hamlets (Tower Hamlets Council) is procuring a Provider to deliver landscaping works to Stepney Park School playground. This includes creation of a new MUGA pitch, play equipment, soft and hard landscaping and tarmac works. These works must be completed and fully handed over prior to the start of the autumn term 2026. The scope covers the completion of playground works to achieve full operational readiness, Building Control approval and compliance with all statutory and educational requirements. The works include detailed design of the landscaping package from the RIBA stage 3 packages provided within this tender.

Summary: The London Borough of Tower Hamlets is currently at the tender stage for the procurement of landscaping works at Stepney Park School playground, entitled the "HAR6171 Smithy Street - Infill Development Scheme". The procurement process, classified under the construction work for school buildings industry category, involves the creation of a sports pitch, play equipment, landscaping, and tarmac works. The works must be concluded before the autumn term of 2026 to achieve full operational readiness. This open procedure tender specifies that electronic submissions in English are permissible, with key deadline dates including tender period end on 19th May 2026, enquiry period closure on 11th May 2026, and award period conclusion on 3rd June 2026. The contract period is scheduled to commence on 22nd June 2026 and conclude on 30th November 2027. The anticipated contract value is £840,000.

Display energy certificate, TM44 and EMS portal

Description: Supply of Display energy certificate, TM44 and EMS portal> Further information in Tender documents.

Summary: The Medicines and Healthcare products Regulatory Agency (MHRA) is initiating a public procurement tender for the supply of services in the energy-management sector. The project, titled "Display energy certificate, TM44 and EMS portal," requires expertise in energy-management services and survey services. The procurement method is an open competition, and interested parties should register and apply via the Atamis e-sourcing portal. Located in London, this procurement process is currently at the tender stage, with submissions due by 18th May 2026 and enquiry period closing by 13th May 2026. The contract is valued at £72,000, with a net amount of £60,000 and provisions for electronic submissions.